Web26 rows · Mar 15, 2024 · Bristol-Myers Squibb Co (BMY) Bristol-Myers Squibb Market Cap: 141.79B for March 22, 2024 View 4,000+ Financial Data Types: Add Browse Market … WebMay 19, 2024 · The bottom line is that this small-cap biotech could have two FDA-approved anti-cancer agents on the market, along with a major licensing deal with Bristol Myers Squibb, in the not-so-distant future.
Bloomsbury Publishing PLC, BMY:LSE summary - FT.com
WebPre-Market Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is … WebBristol Myers Squibb Co. detailed financials by Barron's. View BMY business summary and company performance, for a clear financial breakdown. microsoft word online öffnen
Bristol-Myers Squibb Co, BMY:NYQ summary - FT.com
WebApr 10, 2024 · First Interstate Bank decreased its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Get Rating) by 2.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. ... Bristol-Myers Squibb has a 1-year low of $65.28 and a 1-year high of $81.43. The firm has a market cap of … WebSector Industry Market Cap Revenue; Medical: Medical - Biomedical and Genetics: $148.788B: $46.159B: Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. WebApr 11, 2024 · With Bristol Myers Squibb Co stock trading at $70.74 per share, the total value of Bristol Myers Squibb Co stock (market capitalization) is $148.47B. Bristol Myers Squibb Co stock was originally listed at a price of $47.32 in Dec 31, 1997. If you had invested in Bristol Myers Squibb Co stock at $47.32, your return over the last 25 years … new shingles shot name